Ponatinib treatment promotes arterial thrombosis and hyperactive platelets
Alona Merkulova,
Steven C. Mitchell,
Evi X. Stavrou,
Gabriel L. Forbes,
Alvin H. Schmaier
Affiliations
Alona Merkulova
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH
Steven C. Mitchell
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH
Evi X. Stavrou
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH; Department of Medicine, VA Northeast Ohio Healthcare System, Cleveland, OH
Gabriel L. Forbes
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH
Alvin H. Schmaier
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH; University Hospitals Cleveland Medical Center, Cleveland, OH; Alvin H. Schmaier, Case Western Reserve University, University Hospitals Cleveland Medical Center, 2103 Cornell Rd, WRB2-130, Cleveland, OH 44106-7284
